Comment on

• Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection.

  Gessain A. Gessain A. J Neurovirol. 1996 Oct;2(5):299-306. doi: 10.3109/13550289609146894. J Neurovirol. 1996. PMID: 8912206 Review.
• Molecular aspects of HTLV-I: relationship to neurological diseases.

  Wigdahl B, Brady JN. Wigdahl B, et al. J Neurovirol. 1996 Oct;2(5):307-22. doi: 10.3109/13550289609146895. J Neurovirol. 1996. PMID: 8912207 Review. No abstract available.
• Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotrophic virus type I associated myelopathy/tropical spastic paraparesis patients.

  Fox RJ, Levin MC, Jacobson S. Fox RJ, et al. J Neurovirol. 1996 Oct;2(5):323-9. doi: 10.3109/13550289609146896. J Neurovirol. 1996. PMID: 8912208
• Mutation rates in LTR of HTLV-1 in HAM/TSP patients and the carriers are similarly high to Tax/Rex-coding sequence.

  Saito M, Furukawa Y, Kubota R, Usuku K, Izumo S, Osame M, Yoshida M. Saito M, et al. J Neurovirol. 1996 Oct;2(5):330-5. doi: 10.3109/13550289609146897. J Neurovirol. 1996. PMID: 8912209
• Analysis of the expression directed by two HTLV-I promoters in transgenic mice.

  Coscoy L, Gonzalez-Dunia D, Chirinian-Swan S, Brahic M, Ozden S. Coscoy L, et al. J Neurovirol. 1996 Oct;2(5):336-44. doi: 10.3109/13550289609146898. J Neurovirol. 1996. PMID: 8912210
• Fifteen years of follow-up on HTLV-I positive and HTLV-I negative spastic paraparesis patients in southwestern Colombia, South America.

  Zaninovic V, Leon-S FE. Zaninovic V, et al. J Neurovirol. 1996 Oct;2(5):357-60. doi: 10.3109/13550289609146901. J Neurovirol. 1996. PMID: 8912213 No abstract available.